Month: February 2011

Palatin Technologies, Inc. Announces Pricing of Public Offering of Common Stock and Warrants

CRANBURY, N.J., Feb. 24, 2011 /PRNewswire/ — Palatin Technologies, Inc. (NYSE Amex: PTN) today announced the pricing of its underwritten public offering of 23,000,000 units, consisting of 23,000,000 shares of its common stock, Series A Warrants to purchase 2,000,000 shares of its common stock and Series B Warrants to purchase 21,000,000 shares of its common …

Palatin Technologies, Inc. Announces Pricing of Public Offering of Common Stock and Warrants Read More »

Palatin Technologies, Inc. Announces Proposed Public Offering of Common Stock and Warrants

CRANBURY, N.J., Feb. 23, 2011 /PRNewswire/ — Palatin Technologies, Inc. (NYSE Amex: PTN) today announced that it intends to offer and sell units consisting of shares of its common stock and warrants to purchase common stock in an underwritten public offering. The offering is subject to market conditions and there can be no assurance as …

Palatin Technologies, Inc. Announces Proposed Public Offering of Common Stock and Warrants Read More »

Palatin Technologies, Inc. December 31, 2010 Quarter Results; Teleconference and Webcast to be Held on February 24, 2011

CRANBURY, N.J., Feb. 18, 2011 /PRNewswire/ — Palatin Technologies, Inc. (NYSE Amex: PTN) will host a conference call and webcast on February 24, 2011 at 11:00 a.m. Eastern Time to discuss its quarter ended December 31, 2010 financial results and plans for its programs under development.   Schedule for the Financial Results Press Release, Conference …

Palatin Technologies, Inc. December 31, 2010 Quarter Results; Teleconference and Webcast to be Held on February 24, 2011 Read More »

Palatin Technologies, Inc. Reports Second Quarter Fiscal Year 2011 Results

CRANBURY, N.J., Feb. 15, 2011 /PRNewswire/ — Palatin Technologies, Inc. (NYSE Amex: PTN) a biopharmaceutical company dedicated to the development of peptide mimetic and small molecule agonist compounds with a focus on melanocortin and natriuretic peptide receptor systems, today announced results for its second quarter ended December 31, 2010.  Palatin reported a net loss of …

Palatin Technologies, Inc. Reports Second Quarter Fiscal Year 2011 Results Read More »

Palatin Technologies Listing Compliance Plan Accepted by NYSE Amex

CRANBURY, N.J., Feb. 4, 2011 /PRNewswire/ — Palatin Technologies, Inc. (NYSE Amex: PTN) reported that its exchange listing compliance plan has been accepted by the NYSE Amex. Palatin has been granted an extension until May 26, 2011 to regain compliance with stockholders’ equity requirements under Section 1003(a)(iii) of the NYSE Amex Company Guide and until …

Palatin Technologies Listing Compliance Plan Accepted by NYSE Amex Read More »

Scroll to Top